You are here
VINCERE BIOSCIENCES INC
Company Information
Information
UEI: UFN3TELC89N7
# of Employees: 7
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Evaluation of USP30 small molecule inhibitors in models relevant to Cardiac Aging
Amount: $299,497.00ABSTRACT Vincere Biosciences has proprietary USP30 inhibitor small molecules being optimized in vivo towards development candidates for heart failure (HF) and cardiac aging. HF is an age-related disor ...
SBIRPhase I2022Department of Health and Human Services National Institutes of Health -
Discovery and Development of USP30 inhibitors as Disease-Modifying Therapy for Parkinson's disease.
Amount: $251,987.00PROJECT SUMMARY/ABSTRACTThe proposed Phase I research is designed to establish the technical/scientific merit and feasibility of developing first/best-in-class, USP30 inhibitors for the treatment of P ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health